Loading

Slide Innovative Solutions Inspired by Patients Formulated by Menlo CLICK HERE FOR STATEMENT ON COVID-19 Improving patient lives by working to develop innovations in dermatology and beyond.

Foamix Pharmaceuticals

Menlo Therapeutics has combined with Foamix Pharmaceuticals creating a leading biopharma company focused on the commercialization and development of therapeutics to serve patients in the dermatology space.
null

Leadership

Our leadership team brings together significant clinical development, regulatory, manufacturing and commercialization experience to advance therapeutics for the treatment of several conditions with significant unmet medical need.
null

Board of Directors

Our experienced board of directors consists of David Domzalski, Steve Basta, Sharon Barbari, Rex Bright, Tony Bruno, and Elisabeth Sandoval.

Diversified Dermatology-Focused Pipeline with Near Term Milestones


Amzeeq Zilxi FCD105 Foam
*Safety and efficacy of this investigational product have not been established.
There is no guarantee that pipeline products will receive FDA approval or become commercially available.

Diversified Dermatology-Focused Pipeline with Near Term Milestones

Amzeeq Zilxi FCD105 Foam
*Safety and efficacy of this investigational product have not been established. There is no guarantee that pipeline products will receive FDA approval or become commercially available.
Newsroom